ID

33877

Description

Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Mots-clés

Versions (1)
  1. 05/01/2019 05/01/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

5 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B

Anglais

Concomitant Vaccination

1 Formulaires  
Concomitant Vaccination
Description

Concomitant Vaccination

Alias
UMLS CUI-1
C0042196
UMLS CUI-2
C2347852
Has any vaccines other than the study vaccine(s) been administered at ANY time during the study period or within 30 days prior to the first dose of study vaccine(s)?
Description

Vaccination, Concomitant Agent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2347852
Trade / Generic Name
Description

Vaccines, Name

Type de données

text

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C0027365
Administration date
Description

Vaccination, Concomitant Agent, Date in time

Type de données

date

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0011008
Retour au début de la page

Similar models

Concomitant Vaccination

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Concomitant Vaccination
C0042196 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Vaccination, Concomitant Agent
Item
Has any vaccines other than the study vaccine(s) been administered at ANY time during the study period or within 30 days prior to the first dose of study vaccine(s)?
boolean
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Vaccines, Name
Item
Trade / Generic Name
text
C0042210 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Vaccination, Concomitant Agent, Date in time
Item
Administration date
date
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial